GreatBay Bio Showcases "Dual-Speed" Advantage at BPI West 2025 Ahead of IPO Filing
GBB
AI Biomedical R&D Company
Recently, the three-day BPI US West 2025 concluded at the San Diego Convention Center in the United States, aiming to shorten the cycle from lab to clinic.
Dr. Liang Chen, Co-founder and CEO of Great Bay Bio, attended the exhibition and delivered a speech, elaborating on the "dual-speed" advantages of GBB's cell line development using cutting-edge technologies such as targeted integration. He also explained how Great Bay Bio completes the enormous workload from target/antibody drug discovery to early CMC within 8 months by integrating multiple drug discovery and CMC platforms.
▲GBB Co-Founder and CEO Dr. Liang Chen Delivers a Speech
Traditional cell line construction methods take several months from cell transfection to RCB. With its site-specific integration technology, GBB's AlfaCell platform completes this process in just 6 weeks, significantly improving efficiency.
Due to the homogeneity of cell pools constructed by targeted integration technology,GBB AlfaCell PlatformThe quality of the cell pool is equivalent to that of monoclonal, which can quickly predict product quality data and plan subsequent process development in advance.
GBB's Intelligent Drug Development Ecosystem integrates multiple intelligent drug discovery and CMC platforms, covering drug discovery, molecular sequence generation and optimization, cell line construction, and media supply. By accelerating drug development at different stages, GBB can complete the extensive workload from target/antibody drug discovery to early CMC within 8 months.
▲Dual-Fast Advantage & 8 Months to Complete from Target/Antibody Drug Discovery to Early CMC
GBB leverages its "rapid" advantage to the fullest in every aspect of biopharmaceutical development, fulfilling the urgent desire of global partners to advance industrialization when initiating new projects.For more information, please contact us.
▲Great Bay Bio Attends BPI West 2025
Tel: 400 079 8808
18926497707 (Same number for WeChat)
Email: BD@greatbay-bio.com
